Sign inJoin waitlistJoin the waitlist

RS

Randeep Sangha

Medical Oncology

Credentials: ·

Research

Five-Year Survival Outcomes With Nivolumab Plus Ipilimumab Versus Chemotherapy as First-Line Treatment for Metastatic Non-Small-Cell Lung Cancer in CheckMate 227
Journal of Clinical Oncology · 2023 · 381 citations
EV-101: A Phase I Study of Single-Agent Enfortumab Vedotin in Patients With Nectin-4-Positive Solid Tumors, Including Metastatic Urothelial Carcinoma
Journal of Clinical Oncology · 2020 · 302 citations
Safety and activity of the anti-CD79B antibody-drug conjugate polatuzumab vedotin in relapsed or refractory B-cell non-Hodgkin lymphoma and chronic lymphocytic leukaemia: a phase 1…
The Lancet Oncology · 2015 · 277 citations

David Gandara
8 papers · 1 as a fellow
Primo Lara
6 papers
AD
Angela Davies
5 papers
Aliyah Pabani
3 papers · 3 as a fellow
DL
Derick Lau
3 papers
IF
Ian Flinn
3 papers
Julie Brahmer
3 papers
NB
Naveen Basappa
3 papers
RJ
Rosalyn Juergens
3 papers
CH
Cheryl Ho
2 papers
DH
Daniel Heng
2 papers
EH
Elisabeth Heath
2 papers